Protagonist Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTGX and other ETFs, options, and stocks.About PTGX
Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943.
CEODinesh V. Patel
CEODinesh V. Patel
Employees126
Employees126
HeadquartersNewark, California
HeadquartersNewark, California
Founded2006
Founded2006
Employees126
Employees126
PTGX Key Statistics
Market cap3.37B
Market cap3.37B
Price-Earnings ratio12.95
Price-Earnings ratio12.95
Dividend yield—
Dividend yield—
Average volume2.09M
Average volume2.09M
High today$56.55
High today$56.55
Low today$53.53
Low today$53.53
Open price$55.34
Open price$55.34
Volume1.20M
Volume1.20M
52 Week high$60.60
52 Week high$60.60
52 Week low$24.22
52 Week low$24.22
PTGX News
Simply Wall St 5d
Protagonist Therapeutics, Inc.'s Shares Climb 44% But Its Business Is Yet to Catch UpProtagonist Therapeutics, Inc. ( ) shares have had a really impressive month, gaining 44% after a shaky period beforehand. Looking back a bit further, it's enco...
Analyst ratings
91%
of 11 ratingsBuy
90.9%
Hold
9.1%
Sell
0%